AzTrials
AzTrials

Healthy Toddlers 12-36 Months of Age With Mild or Moderate MalnutritionKEEP GrowingNCT05088590

Growing Up Formula Versus Nutritional Supplements: Effect on Catch up Growth, Micronutrient Status, and Solid Foods Intake in Toddlers With Mild or Moderate Malnutrition

A study testing Enfagrow® Neuropro Toddler Nutritional Drink and Pediasure® Grow & Gain Protein Shake for Kids in people with Healthy Toddlers 12-36 Months of Age With Mild or Moderate Malnutrition, run by University of Colorado, Denver at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This is a pilot study to test how a growing-up formula (GUF) compares to a common nutritional supplement (NS), which is regularly used to help toddlers (ages 12-36 months) gain weight. Read more about this study

Who is it for?
Ages 12 to 36 months
What is being tested?
Enfagrow® Neuropro Toddler Nutritional Drink and Pediasure® Grow & Gain Protein Shake for Kids
Could I receive a placebo?
No, everyone receives an active treatment
How many people
41 participants
Where
1 siteUnited States
Study dates
27 Aug 2021to 1 Dec 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 to 36 months
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Healthy toddlers 12-36 months of age with mild or moderate malnutrition will be defined by at least one of the following indicators:
  • Weight-for-length z-score between -1.0 and -2.9 for children less than 2 years of age using the WHO growth standards; or
  • BMI z-score between -1 to -2.9 for children between 2 and 3 years of age using the CDC growth standards; or
  • Middle upper-arm circumference (MUAC) z-scores between -1 to -2.9 using the WHO growth references; or
  • Percentage of median ideal body weight of 70-89% (using the 50th percentile of the aforementioned growth standards).

Who cannot join

  • Toddlers currently on or with history of tube feeding or with chronic health conditions that influence eating (e.g., food allergies, genetic disorders or developmental disabilities, oral motor difficulties that require sensory or feeding therapy).
  • Toddlers who were born at less than 34 weeks gestation, as they may have lingering feeding challenges.
  • Toddlers with gastroesophageal reflux disease (GERD) requiring medications or hydrolyzed formula or any type of esophageal disorders will be excluded.
  • Toddlers with a history of infant reflux will not be excluded. The PI will make this distinction after a detailed history and record review.
  • Families who do not speak English or Spanish in the home.
  • Toddlers with suspected malabsorption or conditions that increased metabolic demands such as congenital heart defects.
  • Toddlers who have a diagnosed allergy to cow's milk.
  • The PI will use their clinical discretion to ascertain patient eligibility.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Children's Hospital Colorado

    Aurora, Colorado, 80045

Other trials in United States

About this study

This is a pilot study to test how a growing-up formula (GUF) compares to a common nutritional supplement (NS), which is regularly used to help toddlers (ages 12-36 months) gain weight. This study will look at whether GUF helps to increase solid food intake for children who are thought to be "picky eaters" and see the effects on growth compared with the NS. To date, it is not clear if GUFs help to increase intake of solid foods. Participants will be placed into one of the two study arms: Enfagrow (GUF) or Pediasure (standard NS).

Being tested
Enfagrow® Neuropro Toddler Nutritional Drink, Pediasure® Grow & Gain Protein Shake for Kids

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Enfagrow® Neuropro Toddler Nutritional DrinkDietary supplement

    Enfagrow® Neuropro Toddler Nutritional Drink to be consumed per day (equivalent to 40 mL per kg, rounded to the nearest ounce)

  • Pediasure® Grow & Gain Protein Shake for KidsDietary supplement

    Pediasure® Grow \& Gain Protein Shake for Kids to be consumed per day (equivalent to 40 mL per kg, rounded to the nearest ounce)

Study groups in NCT05088590
Study groupRoleWhat they receive
Growing Up Formula (GUF)ExperimentalNot described
Receives: Dietary Supplement: Enfagrow® Neuropro Toddler Nutritional Drink
Standard Nutritional Supplement (NS)Active comparatorNot described
Receives: Dietary Supplement: Pediasure® Grow & Gain Protein Shake for Kids

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Dietary intake from solid foods - Total proteins in grams

    1. Amount of intake of food groups from age-appropriate solid foods;
    2. Intake of calories from age-appropriate solid foods;
    3. Intake of micronutrients from age-appropriate solid foods;
    4. Proportion of calories consumed from age-appropriate solid foods compared with the assigned supplement;
    5. Proportion of micronutrients consumed from age-appropriate solid foods compared with the assigned supplement

    Measured: At baseline

  2. Dietary intake from solid foods - Total grains in grams

    1. Amount of intake of food groups from age-appropriate solid foods;
    2. Intake of calories from age-appropriate solid foods;
    3. Intake of micronutrients from age-appropriate solid foods;
    4. Proportion of calories consumed from age-appropriate solid foods compared with the assigned supplement;
    5. Proportion of micronutrients consumed from age-appropriate solid foods compared with the assigned supplement

    Measured: At baseline

  3. Dietary intake from solid foods - Total vegetables in cups

    1. Amount of intake of food groups from age-appropriate solid foods;
    2. Intake of calories from age-appropriate solid foods;
    3. Intake of micronutrients from age-appropriate solid foods;
    4. Proportion of calories consumed from age-appropriate solid foods compared with the assigned supplement;
    5. Proportion of micronutrients consumed from age-appropriate solid foods compared with the assigned supplement

    Measured: At baseline

  4. Dietary intake from solid foods - Total proteins in grams

    1. Amount of intake of food groups (total proteins in grams, total grains in grams) from age-appropriate solid foods;
    2. Intake of calories from age-appropriate solid foods;
    3. Intake of micronutrients from age-appropriate solid foods;
    4. Proportion of calories consumed from age-appropriate solid foods compared with the assigned supplement;
    5. Proportion of micronutrients consumed from age-appropriate solid foods compared with the assigned supplement

    Measured: At 3 months

  5. Dietary intake from solid foods - Total grains in grams

    1. Amount of intake of food groups from age-appropriate solid foods;
    2. Intake of calories from age-appropriate solid foods;
    3. Intake of micronutrients from age-appropriate solid foods;
    4. Proportion of calories consumed from age-appropriate solid foods compared with the assigned supplement;
    5. Proportion of micronutrients consumed from age-appropriate solid foods compared with the assigned supplement

    Measured: At 3 months

  6. Dietary intake from solid foods - Total vegetables in cups

    1. Amount of intake of food groups from age-appropriate solid foods;
    2. Intake of calories from age-appropriate solid foods;
    3. Intake of micronutrients from age-appropriate solid foods;
    4. Proportion of calories consumed from age-appropriate solid foods compared with the assigned supplement;
    5. Proportion of micronutrients consumed from age-appropriate solid foods compared with the assigned supplement

    Measured: At 3 months

Secondary outcomes (2)
  1. Secondary Outcomes Measures Related to Growth and Nutrition

    Change in micronutrient status between baseline and month 3 as assessed through circulating micronutrient status, measured by laboratory assessment: CBC, Ferritin, sed rate, zinc, DHA, and vitamin D

    Measured: Change from baseline to 3 months

  2. Secondary Outcomes Measures Related to Growth and Nutrition -- Weight gain

    Nutrition status assessment - Change in weight Weight gain: catch up growth is defined by weight gain of >6 g per day[

    Measured: Change from baseline to 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Oct 2021
  2. Study start27 Aug 2021
  3. Primary completion1 Nov 2024
  4. Study completion1 Dec 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
41 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05088590
Sponsor's protocol ID
20-3082
Acronym
KEEP Growing
Status last verified
Feb 2025
First submitted
3 Sep 2021
Last updated
17 Feb 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Enfagrow® Neuropro Toddler Nutritional Drink and Pediasure® Grow & Gain Protein Shake for Kids in people with Healthy Toddlers 12-36 Months of Age With Mild or Moderate Malnutrition, run by University of Colorado, Denver at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Dietary intake from solid foods - Total proteins in grams (time frame: At baseline). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Feb 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in